The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Clinical & Research NewsFull Access

Medication Names and Manufacturers

Published Online:https://doi.org/10.1176/pn.40.21.0030b

The following medications appear in this edition of Med Check:

Amphetamine salts, mixed–extended release: Adderall XR (Shire), generics

Citalopram: Celexa (Forrest)

Clozapine: Clozaril (Novartis)

Fluoxetine: Prozac/Serafem (Lilly), generics

Fluvoxamine: Luvox (Solvay), generics

Methylphenidate–extended release: Concerta (McNeil), Metadate CD/ER (Celltech), Ritalin LA (Novartis)

Mirtazapine: Remeron (Organon)

Paroxetine hydrochloride: Paxil (GSK)

Sertraline: Zoloft (Pfizer)

Valproate: Depakote (Abbott Laboratories)

Venlafaxine–extended release: Effexor-XR (Wyeth)